OncoSwab’s Post

Based in Switzerland, Start-up of the Week OncoSwab is developing a nasal swab test to detect lung cancer in the same way people tested for Covid-19 during the pandemic. According to CEO and co-founder Andrea Stephany Diaz, OncoSwab is about using the non-invasive nasal swab to detect biomarkers “right at the source” – the airway. “We strongly believe this direct detection method has the potential to be more accurate compared to traditional blood-based tests. Designed for simplicity, it can be used both at home and in clinical settings, making it an accessible and cost-effective solution for early lung cancer screening,” she explains. Click the link below to read more. #StartUpOfTheWeek #StartUps #Health #Healthcare #Entrepreneurs https://ow.ly/64zN50RWqgu